What is NDC 72603-121?

72603-121 is the product NDC for Topiramate, Topiramate 50 mg/1 capsule, extended release, listed with the FDA by NorthStar RxLLC. It has 1 package NDC, shown above in 10- and 11-digit form.

NorthStar RxLLC, NDC labeler code 72603. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Topiramate?

277 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Topiramate NDC 72603-121 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)72603-121Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72603-0121Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72603-121-01	7260301210172603012101	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72603-121-01)Marketed from Jan 1, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Topiramate
Generic name (nonproprietary): topiramate
Active ingredients: Topiramate — 50 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: NorthStar RxLLCNDC labeler code 72603
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210278
Marketing start: Jan 1, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 2C19 Inhibitors (Mechanism)Cytochrome P450 3A4 Inducers (Mechanism)Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 72603-121_f853ce07-7fb8-4c3a-96bc-9f4990f73351SPL ID f853ce07-7fb8-4c3a-96bc-9f4990f73351

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472603012101 followed by a unit qualifier and the quantity

Package 72603-0121-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 72603-121

What is NDC 72603-121?: 72603-121 is the product NDC for Topiramate, Topiramate 50 mg/1 capsule, extended release, listed with the FDA by NorthStar RxLLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Topiramate.
What is the active ingredient?: Topiramate.
Who is the labeler?: NorthStar RxLLC, NDC labeler code 72603. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Topiramate?: 277 other product NDCs are listed under this name. See all Topiramate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Topiramate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Topiramate	Topiramate 25 mg/1	Capsule, Extended releaseOral	Cranbury Pharmaceuticals, LLC	27808-325	27808-0325-01
Topiramate	Topiramate 50 mg/1	Capsule, Extended releaseOral	Cranbury Pharmaceuticals, LLC	27808-326	27808-0326-01
Topiramate	Topiramate 100 mg/1	Capsule, Extended releaseOral	Cranbury Pharmaceuticals, LLC	27808-327	27808-0327-01
Topiramate	Topiramate 150 mg/1	Capsule, Extended releaseOral	Cranbury Pharmaceuticals, LLC	27808-328	27808-0328-01
Topiramate	Topiramate 200 mg/1	Capsule, Extended releaseOral	Cranbury Pharmaceuticals, LLC	27808-329	27808-0329-01
topiramate	Topiramate 50 mg/1	Tablet, Film coatedOral	St. Mary's Medical Park Pharmacy	60760-952	60760-0952-60
topiramate	Topiramate 100 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0357	67046-0357-03
topiramate	Topiramate 100 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-1691	67046-1691-03
Topiramate	Topiramate 25 mg/1	Tablet, Film coatedOral	Unit Dose Solutions, Inc.	87441-079	87441-0079-01
Topiramate	Topiramate 100 mg/1	TabletOral	Coupler LLC	67046-1688	67046-1688-03

All 278 Topiramate NDCs

Other NDCs under ANDA 210278

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210278
Product	Strength	Form · route	Labeler	Product NDC
Topiramate	Topiramate 25 mg/1	Capsule, Extended releaseOral	NorthStar RxLLC	72603-120
Topiramate	Topiramate 150 mg/1	Capsule, Extended releaseOral	NorthStar RxLLC	72603-123
Topiramate	Topiramate 100 mg/1	Capsule, Extended releaseOral	NorthStar RxLLC	72603-122
Topiramate	Topiramate 200 mg/1	Capsule, Extended releaseOral	NorthStar RxLLC	72603-124
Topiramate	Topiramate 150 mg/1	Capsule, Extended releaseOral	Glenmark Pharmaceuticals Inc., USA	68462-370
Topiramate	Topiramate 100 mg/1	Capsule, Extended releaseOral	Glenmark Pharmaceuticals Inc., USA	68462-374
Topiramate	Topiramate 200 mg/1	Capsule, Extended releaseOral	Glenmark Pharmaceuticals Inc., USA	68462-371
Topiramate	Topiramate 25 mg/1	Capsule, Extended releaseOral	Glenmark Pharmaceuticals Inc., USA	68462-372
Topiramate	Topiramate 50 mg/1	Capsule, Extended releaseOral	Glenmark Pharmaceuticals Inc., USA	68462-373